![](/img/cover-not-exists.png)
HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors
Dorte Lisbet Nielsen, Michael Andersson, Claus KambyVolume:
35
Year:
2009
Language:
english
Pages:
137
DOI:
10.1016/j.ctrv.2008.09.003
File:
PDF, 303 KB
english, 2009